What’s New in the 2026 Medicare Final Rule — And What It Means for You

CMS has finalized a broad set of updates under the Contract Year 2026 Policy and Technical Changes to the Medicare Advantage, Prescription Drug, Cost Plan, and PACE Programs (CMS-4205-F). These changes continue the implementation of the Inflation Reduction Act (IRA) and strengthen beneficiary protections, affordability, and care coordination across Medicare and Medicaid programs.

Insulin Cost Cap: Making Diabetes Management More Affordable

CMS has reaffirmed and codified the $35 monthly insulin cost cap first introduced by the IRA.Beginning in Contract Year 2026, Medicare Part D plans must charge the lesser of:

• $35 for a one-month supply,

• 25 percent of the “maximum fair price,” or

• 25 percent of the negotiated price.

  
  

This means no deductible applies to covered insulin products, and beneficiaries will continue to enjoy predictable, affordable costs.

For many seniors, insulin previously cost between $100 and $400 a month. The cap offers stability and allows savings to be redirected toward other diabetes essentials such as syringes, insulin pens, glucose monitors, and sensors—helping patients stay on track with their care plans.

Free Adult Vaccines Under Medicare: A Win for Preventive Care

The 2026 rule maintains Medicare’s zero-cost coverage for all ACIP-recommended adult vaccines under Part D.First implemented in 2023 through the IRA, this protection continues forward—ensuring beneficiaries pay no deductible, coinsurance, or copayment for vaccines such as:

• Pneumococcal (pneumonia)

• Shingles (Herpes Zoster)

• Hepatitis B (for at-risk individuals)

• Tdap (tetanus, diphtheria, pertussis)

• Influenza (flu)

  
  

Removing cost-sharing barriers encourages higher vaccination rates and reduces preventable illness among older adults. (COVID-19 vaccine coverage remains governed under separate CMS policy and may evolve over time.)

Medicare Prescription Payment Plan (MPPP)

Starting in 2026, Medicare Part D and MA-PD enrollees can spread their prescription cost-sharing into monthly payments instead of paying large amounts upfront.CMS finalized requirements around election notices, renewals, voluntary termination, and pharmacy participation—making the payment plan option more accessible and transparent.

Integrated Care for Dually Eligible Members

To improve coordination between Medicare and Medicaid, Dual-Eligible Special Needs Plans (D-SNPs) must:

• Issue combined Medicare-Medicaid ID cards, and

• Conduct a single, integrated health-risk assessment for both programs.

  
  

Plans must actively involve members or their representatives when developing individualized care plans—helping ensure a seamless experience for people who receive both Medicare and Medicaid benefits.

Timely Prescription Drug Event (PDE) Submissions

CMS codified clear deadlines for submitting and correcting PDE data to improve payment accuracy:

• Initial PDEs: within 30 days of claim receipt

• Adjustments/deletions: within 90 days of identifying an issue

• Selected drugs: within 7 days

  
  

Pharmacy Requirements under the Drug Price Negotiation Program

All network pharmacies must enroll in CMS’s Medicare Transaction Facilitator Data Module (MTF DM) and certify data accuracy.This ensures correct claims information and access to negotiated drug prices under the Medicare Drug Price Negotiation Program.

Stronger Inpatient Coverage Protections

CMS clarified that Medicare Advantage (MA) plans must notify both providers and enrollees when coverage decisions are made for inpatient care.Plans cannot bill enrollees until a payment determination is issued and may not rely on post-admission information to deny the appropriateness of a hospital stay.These clarifications aim to reduce confusion and prevent unexpected out-of-pocket costs when a patient’s hospital status is reviewed.

Risk Adjustment and Data Updates

CMS modernized technical definitions tied to diagnosis coding, removing references to a specific ICD version, and now formally requires PACE and Cost plans to submit risk-adjustment data.These updates keep risk-score calculations accurate and consistent across programs.

Why It Matters

Together, these changes reflect CMS’s continued focus on:

• Lowering costs for beneficiaries,

• Making preventive care accessible, and

• Integrating Medicare and Medicaid services for more coordinated, person-centered care.

  
  

Organizations should review their compliance and operational processes now to ensure readiness for Contract Year 2026 implementation.

Watch the full episode above or listen everywhere you find your podcasts!